BBNXBeta Bionics, Inc.
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Choppy, but holding above its 200-day average. Oversold (RSI 15). Price is +12% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BBNX is trading
Beta Bionics, Inc. is −21% over the past year while the S&P 500 is +18%: 39 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +12%
vs 200-day average · a clear uptrend
- RSI (14)
- 15
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 45%
Below its 52-week high
Details›
- Last close2026-10-08
- $17.44
- 1 monthS&P 500 +1.6%
- +0.17%
- 1 yearS&P 500 +18%
- −21%
- vs 50-day average$18.56
- −6.0%
- 52-week high
- $31.99
- 52-week low
- $8.86
- Annualised volatility
- 85%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$473K
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Devices
The closest names by size in the same industry